Cell Attachment Capacity and Compounds of Fibrin Membranes Isolated from Fresh Frozen Plasma and Cryoprecipitate

被引:3
|
作者
Hinsenkamp, Adel [1 ]
Kun, Kiara [1 ]
Gajnut, Fatime [1 ]
Majer, Aliz [1 ]
Lacza, Zsombor [2 ,3 ]
Hornyak, Istvan [1 ]
机构
[1] Semmelweis Univ, Inst Translat Med, H-1094 Budapest, Hungary
[2] Orthosera GmbH, A-3500 Krems An Der Donau, Austria
[3] Univ Phys Educ, Inst Sports & Hlth Sci, H-1123 Budapest, Hungary
关键词
fibrinogen; fibrin; cryoprecipitate; mesenchymal stem cells;
D O I
10.3390/membranes11100783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrin membranes are widely used in regenerative medicine because they are biocompatible, biodegradable, contain growth factors, and support cell attachment. Most commonly they are produced from serum, but they can also be isolated from activated plasma. To increase the fibrinogen concentration of plasma, cryoprecipitate isolation is a possible solution. In this work, cryoprecipitate was prepared from fresh frozen plasma, isolated by plasmapheresis. The concentration of cellular elements, fibrinogen, total protein, and immunoglobulins among others was measured in different concentrations of cryoprecipitates. After activation with Ca-gluconate, fibrin membranes were produced in different thicknesses, and human mesenchymal stem cells were seeded onto the membranes. They were visualized by live-dead staining and their viability was determined by XTT. The platelet-derived growth factor AB content was quantified by ELISA. Our results showed that fibrinogen and platelet concentration can be multiplied in plasma by cryoprecipitate isolation, which affects the thickness and slightly the growth factor content of the membranes. According to live-dead staining, the thickness of the membranes does not influence cell attachment, and XTT measurement did not reveal a significant difference in cell attachment capacity either; however, a growing trend could be observed in the case of some membranes.
引用
收藏
页数:13
相关论文
共 18 条
  • [1] Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability
    Hwang, Ji Hui
    Tung, John-Paul
    Harkin, Damien G.
    Flower, Robert L.
    Pecheniuk, Natalie M.
    TRANSFUSION, 2024, 64 (09) : 1709 - 1718
  • [2] Hemostatic capability of ultrafiltrated fresh frozen plasma compared to cryoprecipitate
    Ichikawa, Junko
    Iba, Toshiaki
    Okazaki, Ryouta
    Fukuda, Tomoki
    Kodaka, Mitsuharu
    Komori, Makiko
    Levy, Jerrold H.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] The Possible Advantages of Cryoprecipitate Prepared From Fresh Frozen Plasma From Blood Stored for 24 Hours
    Philip, Joseph
    Kumarage, Samantha
    Chatterjee, Tathagata
    Kumar, Sudeep
    Mahi, Rajeev
    LABMEDICINE, 2014, 45 (02): : 111 - 115
  • [4] Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma
    Caudill, Jonathan S. C.
    Nichols, William L.
    Plumhoff, Elizabeth A.
    Schulte, Sandra L.
    Winters, Jeffrey L.
    Gastineau, Dennis A.
    Rodriguez, Vilmarie
    TRANSFUSION, 2009, 49 (04) : 765 - 770
  • [5] Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light
    Cid, Joan
    Caballo, Carolina
    Pino, Marc
    Galan, Ana M.
    Martinez, Nuria
    Escolar, Gines
    Diaz-Ricart, Maribel
    TRANSFUSION, 2013, 53 (03) : 600 - 605
  • [6] Adjunctive Fresh Frozen Plasma Versus Adjunctive Cryoprecipitate in Cardiac Surgery Patients Receiving Platelets for Perioperative Bleeding
    Fletcher, Calvin M.
    Hinton, Jake, V
    Perry, Luke A.
    Greifer, Noah
    Williams-Spence, Jenni
    Segal, Reny
    Smith, Julian A.
    Coulson, Tim G.
    Reid, Christopher M.
    Bellomo, Rinaldo
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2025, 39 (03) : 584 - 593
  • [7] Allogeneic single-donor cryoseal produced from fresh-frozen quarantine apheresis plasma as alternative for multidonor or autologous fibrin sealants
    Hazelaar, Sandra
    Dijkstra-Tiekstra, Margriet J.
    de Korte, Dirk
    de Wildt-Eggen, Janny
    TRANSFUSION, 2012, 52 (03) : 517 - 523
  • [8] Proteomic Characterization of Transfusable Blood Components: Fresh Frozen Plasma, Cryoprecipitate, and Derived Extracellular Vesicles via Data-Independent Mass Spectrometry
    Hwang, Ji Hui
    Lai, Andrew
    Tung, John-Paul
    Harkin, Damien G.
    Flower, Robert L.
    Pecheniuk, Natalie M.
    JOURNAL OF PROTEOME RESEARCH, 2024, 23 (10) : 4508 - 4522
  • [9] British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding
    Green, Laura
    Bolton-Maggs, Paula
    Beattie, Craig
    Cardigan, Rebecca
    Kallis, Yiannis
    Stanworth, Simon J.
    Thachil, Jecko
    Zahra, Sharon
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 54 - 67
  • [10] An Observational Study of the Fresh Frozen Plasma: Red Blood Cell Ratio in Postpartum Hemorrhage
    Pasquier, Pierre
    Gayat, Etienne
    Rackelboom, Thibaut
    La Rosa, Julien
    Tashkandi, Abeer
    Tesniere, Antoine
    Ravinet, Julie
    Vincent, Jean-Louis
    Tsatsaris, Vassilis
    Ozier, Yves
    Goffinet, Francois
    Mignon, Alexandre
    ANESTHESIA AND ANALGESIA, 2013, 116 (01) : 155 - 161